Scotland will soon begin a large prospective trial of early screening for lung cancer in high-risk patients using a simple blood test. The test, called EarlyCDT-Lung, has been in use and trials in the United States for more than two years.
Body mass index appears to be inversely associated with the risk for lung cancer, even after smoking status is carefully taken into account. A new prospective study found this association was restricted to current and former smokers and was actually stronger after adjustments for smoking were made.
Researchers at the University of British Columbia in Vancouver, Canada have sequenced and analyzed over 100 triple-negative breast tumors at the time of diagnosis, the first in-depth genomic analysis of this heterogeneous breast cancer subtype.
Researchers have identified a marker of DNA damage that may be able to predict a patient’s response to platinum-based chemotherapy agents such as cisplatin and carboplatin.
Children diagnosed with non-central nervous system cancers at a very young age tend to reach some neurodevelopmental milestones later than healthy children, according to a new study.
Oral nutritional interventions can improve quality of life and overall nutritional intake in some cancer patients, but do not appear to have any effect on mortality outcomes, according to a recent meta-analysis.
Using detailed patient data and mathematical modeling programs, a US–international team of investigators has concluded that in the US, public health efforts beginning in the 1950s prevented nearly 800,000 deaths from lung cancer between 1975 and 2000.
A wide negative margin during breast-conserving surgery should be attempted for women with ductal carcinoma in situ–this is the conclusion from an analysis published today in the Journal of the National Cancer Institute.
Three papers published today show that aspirin, taken daily, may prevent cancer, and could even treat certain cancers.
Endocrine-therapy resistant HER2-negative breast cancer is the most common cause of breast cancer death. The basis for this resistance is heavily studied to identify new ways to treat these patients.